Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases

Explore clinical trials studying Eye Diseases. Study availability and eligibility vary by location and protocol.

10,671 public trials 1,320 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases trial results

Active, not recruiting

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

NCT06864988

Conditions
Eye Diseases, Macular Degeneration, Macular Neovascularization Secondary to Age-Related Macular Degeneration, +3 more
Locations
  • Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States
  • Retinal Research Institute, LLC Scottsdale, Arizona, United States
  • Retina Partners of Northwest Arkansas Springdale, Arkansas, United States
  • California Retina Consultants Bakersfield, California, United States
View all 95 locations
View Trial Details
Active, not recruiting

Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD

NCT04676854

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Hôpital de la Croix-Rousse CHU de LYON Lyon, France
  • Hôpital Pellegrin Bordeaux, France
  • Centre hospitalier intercommunal de Créteil - Service Ophtalmologie Créteil, France
  • Centre Monticelli Paradis Marseille, France
View all 21 locations
View Trial Details
Active, not recruiting

A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

NCT06161584

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • California Retina Consultants (01-026) Bakersfield, California, United States
  • Retina-Vitreous Associates Medical Group (01-020) Beverly Hills, California, United States
  • Illinois Retina Associates (01-035) Fullerton, California, United States
  • Retinal Consultants Medical Group Inc (01-008) Modesto, California, United States
View all 34 locations
View Trial Details
Active, not recruiting

A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001

NCT06852963

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases Hereditary, +7 more
Locations
  • University of Florida College of Medicine Jacksonville, Florida, United States
  • Bascom Palmer Eye Institute - University of Miami Miami, Florida, United States
  • Kellogg Eye Center - University of Michigan Ann Arbor, Michigan, United States
  • Casey Eye Institute - OHSU Portland, Oregon, United States
View Trial Details
Active, not recruiting

Orbital Fractures Registry

NCT03887988

Conditions
Blow Out Fracture of Orbit, Craniocerebral Trauma, Diplopia, +14 more
Locations
  • UC Davis Sacramento, California, United States
  • Medical Center Hamburg Eppendorf Hamburg, Germany
  • Klinikum der LMU München Munich, Germany
  • Eramus MC Rotterdam, Netherlands
View all 14 locations
View Trial Details

Related conditions